EDGAR Filing Documents for 0001654954-17-008137

Form 8-K - Current report:

SEC Accession No. 0001654954-17-008137

Filing Date

2017-09-05

Accepted

2017-09-05 16:20:13

Documents

Period of Report

2017-08-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	sbfm_8k.htm	8-K	25272
2	PRESS RELEASE	sbfm_ex997.htm	EX-99.7	9221
3	IMAGE	img001.jpg	GRAPHIC	11191
	Complete submission text file	0001654954-17-008137.txt		51470

Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4

Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)